The chart above plots the price of JCI over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 32 sessions over that window: $141.99 on 2 June 2026 through $140 on 17 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 31, 2026
JCI insider trades
SEC Form 4 · last 90 days · newest reported trade 19 Aug 2026
Open-market buys0
Open-market sells3
Net sold$4.34M
Non-trade filings4
DateInsiderTypeSharesValue
19 Aug 2026Cohade Pierre EDirectorSell3,300$488K
04 Aug 2026Schlitz Lei ZhangVP & Pres, GP & SolutionsSell23,417$3.58M
09 Jun 2026Grabowski Todd MVP and President, AmericasSell1,800$263K
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
DateInsiderTypeSharesValue
02 Aug 2026Schlitz Lei ZhangVP & Pres, GP & SolutionsTax withheld18,625$2.73M
02 Aug 2026Vandiepenbeeck MarcEVP and CFOTax withheld19,760$2.90M
14 Jul 2026Scalia Christopher MEVP and CHROTax withheld3,901$567K
08 Jun 2026ESTEVES IRENE MDirectorAward937
JCI reported financials
SEC EDGAR XBRL
JCI reported revenue of $23.6B for the fiscal year ended 30 Sep 2025. Net income over the same period was $3.3B.
FigureReportedPeriod
Revenue
$23.6B
30 Sep 2025 fiscal year
Net income
$3.3B
30 Sep 2025 fiscal year
Diluted EPS
$5.03
30 Sep 2025 fiscal year
Total assets
$38.4B
31 Mar 2026 at period end
Total equity
$13.5B
31 Mar 2026 at period end
Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026
JCI earnings
SEC EDGAR
DatePeriodEPSRevenue
31 Mar 2026Q2 2026$1.00—
31 Dec 2025Q1 2026$0.85—
30 Sep 2025FY 2025$5.03—
30 Jun 2025Q3 2025$1.07—
31 Mar 2025Q2 2025$0.72—
31 Dec 2024Q1 2025$0.63—
30 Sep 2024FY 2024$2.52—
30 Jun 2024Q3 2024$1.45—
Next report no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
14 of the 45 institutional funds we track reported a JCI position for the quarter ended 30 Jun 2026 — a combined $4.4B; the latest of those filings landed 14 Aug 2026.